Aurora kinase

Aurora kinase
Name	Aurora kinase

Aurora kinase is a family of serine/threonine protein kinases pivotal for mitotic progression, chromosome segregation, and centrosome function. Discovered through genetic and biochemical screens in model organisms, these kinases coordinate mitotic spindle assembly and cytokinesis and are conserved across eukaryotic lineages. Research on Aurora kinase intersects with studies from Gregor Mendel-era genetics through modern investigations at institutions such as Max Planck Society and Broad Institute, and it informs clinical efforts at organizations like National Cancer Institute and European Medicines Agency.

Introduction

Aurora kinases were identified in screens for mitotic regulators alongside discoveries by groups at Harvard University, Massachusetts Institute of Technology, and Cold Spring Harbor Laboratory. Early functional characterization drew on approaches developed by Francois Jacob, Jacques Monod, and methods from Stanford University laboratories. Subsequent structural studies involved facilities at European Molecular Biology Laboratory and Lawrence Berkeley National Laboratory. The family comprises multiple isoforms conserved from Saccharomyces cerevisiae to humans, and their dysregulation has been implicated in tumorigenesis studied at centers like MD Anderson Cancer Center.

Structure and Isoforms

Aurora kinases share a conserved catalytic domain structurally analyzed using methods at Rockefeller University and University of Cambridge. Isoforms differ by N-terminal regulatory domains and subcellular localization signals identified in comparative studies at Yale University and University of Oxford. Three principal human isoforms were delineated in collaborative projects involving University of Tokyo and University of California, San Francisco. High-resolution crystallography performed at Diamond Light Source and Argonne National Laboratory revealed activation-loop conformations analogous to kinases characterized at Sanger Institute.

Biological Functions and Cell Cycle Regulation

Functionally, these kinases orchestrate centrosome maturation and kinetochore-microtubule attachments, topics investigated at Cold Spring Harbor Laboratory and Imperial College London. Mitotic roles were elucidated through genetic models such as Drosophila melanogaster, Caenorhabditis elegans, and Xenopus laevis studied at Princeton University and University of California, Berkeley. Connections to mitotic checkpoints drew on prior work from Paul Nurse and Leland Hartwell laboratories. Research at Johns Hopkins University and University of Pennsylvania linked Aurora activity to cytokinesis, while collaborations with Children's Hospital Boston examined developmental consequences.

Mechanisms of Regulation and Interaction

Regulatory mechanisms include phosphorylation, ubiquitin-mediated degradation, and protein-protein interactions mapped using proteomics platforms at European Bioinformatics Institute and National Institutes of Health. Interactors were identified in screens involving Stanford Linear Accelerator Center resources and mass spectrometry facilities at Massachusetts General Hospital. Cross-talk with cell cycle regulators studied at Cold Spring Harbor Laboratory and Whitehead Institute implicates pathways characterized by researchers at Max Planck Institute for Biochemistry and École Normale Supérieure. Studies at Dana-Farber Cancer Institute and Vanderbilt University described feedback with mitotic kinases and phosphatases.

Role in Disease and Cancer

Aberrant expression and mutation profiles were cataloged by consortia such as The Cancer Genome Atlas and International Cancer Genome Consortium, and clinical correlations were analyzed at Sloan Kettering Institute and Karolinska Institutet. Oncogenic roles were investigated in studies at Memorial Sloan Kettering Cancer Center and Mayo Clinic. Functional links to chromosomal instability emerged from research at Fred Hutchinson Cancer Research Center and Salk Institute. Epidemiological associations were explored with datasets from World Health Organization and Centers for Disease Control and Prevention collaborations. Pediatric and adult malignancies with altered kinase activity were profiled by networks involving St. Jude Children's Research Hospital.

Therapeutic Targeting and Inhibitors

Efforts to develop inhibitors involved pharmaceutical partnerships with GlaxoSmithKline, AstraZeneca, Pfizer, and biotechnology firms such as Roche subsidiaries, with preclinical evaluation at Novartis Institutes for BioMedical Research and Eli Lilly and Company. Clinical trials registered through U.S. Food and Drug Administration and coordinated at academic centers including University College London assessed small molecules that compete with ATP-binding pockets resolved via structural biology at Brookhaven National Laboratory. Resistance mechanisms and combination strategies were tested in studies supported by American Cancer Society grants and trials run through networks like European Organisation for Research and Treatment of Cancer.

Category:Protein kinases Category:Cell cycle Category:Cancer research